Development of a Gene Risk Signature for Patients of Pancreatic Cancer

BACKGROUND: Pancreatic cancer is a highly malignant solid tumor with a high lethality rate, but there is a lack of clinical biomarkers that can assess patient prognosis to optimize treatment. METHODS: Gene-expression datasets of pancreatic cancer tissues and normal pancreatic tissues were obtained f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tao, Chen, Long, Gao, Guili, Liang, Xing, Peng, Junfeng, Zheng, Minghui, Li, Judong, Ye, Yongqiang, Shao, Chenghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759853/
https://www.ncbi.nlm.nih.gov/pubmed/35035831
http://dx.doi.org/10.1155/2022/4136825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759853/
https://www.ncbi.nlm.nih.gov/pubmed/35035831
http://dx.doi.org/10.1155/2022/4136825

Ejemplares similares